ARCHIVES

Cancer Groups Endorse Richard Pazdur for Head of FDA’s New Office of Oncology Drug Products. Five Candidates Are In the Running for the Job, Sources Said.

This article is from The Cancer Letter archive.

Vol. 31 No. 07 | February 18, 2005

Download PDF Visit The Full Archive

Related Articles

Two NCI Officials Leave for Industry, Academia: Carl Barrett Goes to Novartis, Karen Antman Named Provost and Dean at Boston University.

February 18, 2005

ASCO, AACI Ask $1.3 Billion for NCI, Full Funding Of Center Core, Group Grants

May 4, 1984

Promising Results For Glivec In CML Continue, FDA Grants Priority Review

April 27, 2001

Bioethics Commission Report Calls For funding To Derive Stem Cells

September 17, 1999

Also in this issue: ODAC Votes To Strip Breast Cancer Indication From Avastin

July 23, 2010

Letters To The Editor From I-ELCAP’s Claudia Henschke and Steve Walker From Abigail Alliance.

July 8, 2011